ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

8.04%

$6.05

Market Cap $93.65M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	Results of 2012 Annual General Meeting		20/11/12	125.79KB	Share
AVR	AGM Presentation		20/11/12	5.13MB	Share
AVR	Allied announces successful result for Coridon's HPV vaccine	PRICE SENSITIVE	15/11/12	272.32KB	Share
AVR	New contract signals strong year of sales for Allied	PRICE SENSITIVE	07/11/12	252.63KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/12	448.04KB	Share
AVR	Waiver to Listing Rule 10.13.5		25/10/12	246.21KB	Share
AVR	Change in substantial holding		23/10/12	57.29KB	Share
AVR	Notice of Annual General Meeting/Proxy Form		19/10/12	547.15KB	Share
AVR	Full Annual Report to shareholders		19/10/12	3.43MB	Share
AVR	First patients receive Allied's CardioCel	PRICE SENSITIVE	18/10/12	185.72KB	Share
AVR	Annual Report to shareholders		28/09/12	389.51KB	Share
AVR	Allied's CardioCel authorised for early use in patients	PRICE SENSITIVE	26/09/12	198.92KB	Share
AVR	Preliminary Final Report	PRICE SENSITIVE	31/08/12	580.42KB	Share
AVR	Appendix 4C - Fourth Quarter Report	PRICE SENSITIVE	31/07/12	467.39KB	Share
AVR	Quarterly Shareholder Newsletter		27/07/12	1.89MB	Share
AVR	Section 708A Notice		20/07/12	136.08KB	Share
AVR	Appendix 3B		20/07/12	416.41KB	Share
AVR	Allied and CSIRO announce stem cell collaboration	PRICE SENSITIVE	03/07/12	257.49KB	Share
AVR	Appendix 3B		21/06/12	407.26KB	Share
AVR	Allied submits CE Mark application for CardioCel	PRICE SENSITIVE	05/06/12	74.89KB	Share
AVR	Initial Director's Interest Notice		22/05/12	11.69KB	Share
AVR	Appendix 3B		22/05/12	202.46KB	Share
AVR	Director Appointment/Resignation		18/05/12	186.38KB	Share
AVR	Change in substantial holding - The Metal Group Pty Ltd		01/05/12	399.67KB	Share
AVR	Change of Director's Interest Notice x3		01/05/12	291.07KB	Share
AVR	Change in substantial holding		01/05/12	217.16KB	Share
AVR	Cancellation of Unlisted Options		01/05/12	175.24KB	Share
AVR	Appendix 3B		30/04/12	245.16KB	Share
AVR	Notice under S708A and Top 20 Shareholders		30/04/12	215.16KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/12	465.2KB	Share
AVR	Change in substantial holding		27/04/12	43.24KB	Share
AVR	Allied increases stake in Coridon	PRICE SENSITIVE	27/04/12	266.18KB	Share
AVR	Allied closes Rights Issue Capital Raising	PRICE SENSITIVE	24/04/12	274.56KB	Share
AVR	Allied announces Coridon license to vector technology	PRICE SENSITIVE	17/04/12	278.69KB	Share
AVR	Positive Phase II follow up data from CardioCel	PRICE SENSITIVE	05/04/12	182.33KB	Share
AVR	Change to Allied Board and Appendix 3Z		03/04/12	529.6KB	Share
AVR	Allied announces successful implant of GyneCel	PRICE SENSITIVE	29/03/12	269.02KB	Share
AVR	Top 20 Shareholders and Change to Significant Shareholders		27/03/12	2.5MB	Share
AVR	Notice under S708AA		22/03/12	136.17KB	Share
AVR	Offer Document for Non-Renounceable Rights Issue	PRICE SENSITIVE	21/03/12	520.16KB	Share
AVR	Letter to Shareholders		19/03/12	159.84KB	Share
AVR	Notice to Eligible Shareholders of Entitlements Offer		19/03/12	168.81KB	Share
AVR	Allied announces ADAPT Patent granted for Singapore	PRICE SENSITIVE	19/03/12	346.75KB	Share
AVR	Allied undertake capital raise includes notice under S708AA	PRICE SENSITIVE	16/03/12	275.71KB	Share
AVR	Appendix 3B - Placement and Rights Issue		16/03/12	244.71KB	Share
AVR	Trading Halt	PRICE SENSITIVE	14/03/12	22.23KB	Share
AVR	Allied announces successful implant of CardioCel	PRICE SENSITIVE	13/03/12	182.38KB	Share
AVR	Allied announces updated regulatory strategy for CardioCel	PRICE SENSITIVE	05/03/12	183.35KB	Share
AVR	Investor Roadshow Presentation		02/03/12	982.68KB	Share
AVR	Half Yearly Report and Accounts	PRICE SENSITIVE	01/03/12	127.73KB	Share
AVR	Allied's Coridon to develop HPV Vaccine	PRICE SENSITIVE	28/02/12	153.51KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/12	526.44KB	Share
AVR	Appendix 3B - Exercise of options		12/01/12	408.26KB	Share
AVR	Lapse of listed options		12/01/12	155.27KB	Share
AVR +AVX	Avexa Limited - Transfer of Shares/Forms 603 and 604		23/12/11	238.54KB	Share
AVR	Featured on BRR following positive Tissue Heart Valve study		16/12/11	186.85KB	Share
AVR	Appendix 3B - Exercise of Options		08/12/11	406.19KB	Share
AVR +AVX	Change in substantial holding for AVX		08/12/11	216.09KB	Share
AVR	AHZ Appoints Dr Julian Chick to Executive Team		07/12/11	160.38KB	Share
AVR	AHZ Option Expiry Notice		06/12/11	167.16KB	Share
AVR	Positive Results in Tissue Heart Valve Study	PRICE SENSITIVE	05/12/11	556.76KB	Share
AVR	Release of Bell Potter Analyst Report on AHZ website		01/12/11	110.4KB	Share
AVR	Change of Director's Interest Notice x 2		01/12/11	275.88KB	Share
AVR	Appendix 3B		01/12/11	405.98KB	Share
AVR	Results of 2011 Annual General Meeting		29/11/11	333.38KB	Share
AVR	AGM Presentation		29/11/11	368.26KB	Share
AVR	Allied Healthcare Group Appoints a New CEO of Celxcel	PRICE SENSITIVE	22/11/11	332.05KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	31/10/11	526.1KB	Share
AVR	Annual Report to shareholders		27/10/11	6.12MB	Share
AVR	Notice of Annual General Meeting/Proxy Form		27/10/11	555.19KB	Share
AVR	Appendix 3B		20/10/11	406.81KB	Share
AVR	Board Changes and Company Secretary Appointment/Resignation		20/10/11	307.2KB	Share
AVR	Sale of Unmarketable Parcels		18/10/11	423.4KB	Share
AVR	Notice of Breach of Listing Rules		18/10/11	417.67KB	Share
AVR	Replacement Change of Director's Interest Notice		18/10/11	294.53KB	Share
AVR	Replacement Initial Director's Interest Notice		18/10/11	211.66KB	Share
AVR	Response to ASX query		18/10/11	374.72KB	Share
AVR	Re-issue Correction to Appendix 3B		14/10/11	342.24KB	Share
AVR	Appendix 3B		14/10/11	341.21KB	Share
AVR	Allied Healthcare Increases Holding in Coridon	PRICE SENSITIVE	12/10/11	314.93KB	Share
AVR	Coridon Demonstrates 100% Protection using DNA Vaccine	PRICE SENSITIVE	11/10/11	121.21KB	Share
AVR	Appendix 3B and Section 708A(5)(e) Notice		05/10/11	356.98KB	Share
AVR	Annual Report to shareholders		03/10/11	294.83KB	Share
AVR	Corporate Presentation		30/09/11	1.45MB	Share
AVR	$5M Equity Funding Package	PRICE SENSITIVE	30/09/11	144.09KB	Share
AVR	Trading Halt	PRICE SENSITIVE	28/09/11	23.35KB	Share
AVR	Change of Director's Interest Notice x 2		14/09/11	88.12KB	Share
AVR	Appendix 3B - Unlisted Options		02/09/11	186.47KB	Share
AVR	Preliminary Final Report	PRICE SENSITIVE	01/09/11	441.67KB	Share
AVR	Celxcel Granted Tissue Engineering Patent	PRICE SENSITIVE	29/08/11	238.56KB	Share
AVR	Appendix 3B - Exercise of Options		05/08/11	186.07KB	Share
AVR	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/11	508.67KB	Share
AVR	Appendix 3B - Exercise of Options		29/07/11	186.08KB	Share
AVR	Ceasing to be a substantial holder		22/07/11	203.28KB	Share
AVR	Appendix 3B - Exercise of Options		22/07/11	186.08KB	Share
AVR	Becoming a substantial holder from McRae Technology Pty Ltd		20/07/11	1.37MB	Share
AVR	DNA Vaccine Developer Coridon in US Collaboration	PRICE SENSITIVE	20/07/11	243.05KB	Share
AVR	Becoming a substantial holder from The Metal Group Pty Ltd		18/07/11	488.84KB	Share
AVR +AVX	Becoming a substantial holder from AVX		14/07/11	251.64KB	Share
AVR +AVX	Avexa holds 16.9% investment in Allied Healthcare Group		14/07/11	62.35KB	Share

AVR Results of 2012 Annual General Meeting
20/11/12		125.79KB	Share
AVR AGM Presentation
20/11/12		5.13MB	Share
AVR Allied announces successful result for Coridon's HPV vaccine
15/11/12	PRICE SENSITIVE	272.32KB	Share
AVR New contract signals strong year of sales for Allied
07/11/12	PRICE SENSITIVE	252.63KB	Share
AVR Appendix 4C - quarterly
31/10/12	PRICE SENSITIVE	448.04KB	Share
AVR Waiver to Listing Rule 10.13.5
25/10/12		246.21KB	Share
AVR Change in substantial holding
23/10/12		57.29KB	Share
AVR Notice of Annual General Meeting/Proxy Form
19/10/12		547.15KB	Share
AVR Full Annual Report to shareholders
19/10/12		3.43MB	Share
AVR First patients receive Allied's CardioCel
18/10/12	PRICE SENSITIVE	185.72KB	Share
AVR Annual Report to shareholders
28/09/12		389.51KB	Share
AVR Allied's CardioCel authorised for early use in patients
26/09/12	PRICE SENSITIVE	198.92KB	Share
AVR Preliminary Final Report
31/08/12	PRICE SENSITIVE	580.42KB	Share
AVR Appendix 4C - Fourth Quarter Report
31/07/12	PRICE SENSITIVE	467.39KB	Share
AVR Quarterly Shareholder Newsletter
27/07/12		1.89MB	Share
AVR Section 708A Notice
20/07/12		136.08KB	Share
AVR Appendix 3B
20/07/12		416.41KB	Share
AVR Allied and CSIRO announce stem cell collaboration
03/07/12	PRICE SENSITIVE	257.49KB	Share
AVR Appendix 3B
21/06/12		407.26KB	Share
AVR Allied submits CE Mark application for CardioCel
05/06/12	PRICE SENSITIVE	74.89KB	Share
AVR Initial Director's Interest Notice
22/05/12		11.69KB	Share
AVR Appendix 3B
22/05/12		202.46KB	Share
AVR Director Appointment/Resignation
18/05/12		186.38KB	Share
AVR Change in substantial holding - The Metal Group Pty Ltd
01/05/12		399.67KB	Share
AVR Change of Director's Interest Notice x3
01/05/12		291.07KB	Share
AVR Change in substantial holding
01/05/12		217.16KB	Share
AVR Cancellation of Unlisted Options
01/05/12		175.24KB	Share
AVR Appendix 3B
30/04/12		245.16KB	Share
AVR Notice under S708A and Top 20 Shareholders
30/04/12		215.16KB	Share
AVR Appendix 4C - quarterly
30/04/12	PRICE SENSITIVE	465.2KB	Share
AVR Change in substantial holding
27/04/12		43.24KB	Share
AVR Allied increases stake in Coridon
27/04/12	PRICE SENSITIVE	266.18KB	Share
AVR Allied closes Rights Issue Capital Raising
24/04/12	PRICE SENSITIVE	274.56KB	Share
AVR Allied announces Coridon license to vector technology
17/04/12	PRICE SENSITIVE	278.69KB	Share
AVR Positive Phase II follow up data from CardioCel
05/04/12	PRICE SENSITIVE	182.33KB	Share
AVR Change to Allied Board and Appendix 3Z
03/04/12		529.6KB	Share
AVR Allied announces successful implant of GyneCel
29/03/12	PRICE SENSITIVE	269.02KB	Share
AVR Top 20 Shareholders and Change to Significant Shareholders
27/03/12		2.5MB	Share
AVR Notice under S708AA
22/03/12		136.17KB	Share
AVR Offer Document for Non-Renounceable Rights Issue
21/03/12	PRICE SENSITIVE	520.16KB	Share
AVR Letter to Shareholders
19/03/12		159.84KB	Share
AVR Notice to Eligible Shareholders of Entitlements Offer
19/03/12		168.81KB	Share
AVR Allied announces ADAPT Patent granted for Singapore
19/03/12	PRICE SENSITIVE	346.75KB	Share
AVR Allied undertake capital raise includes notice under S708AA
16/03/12	PRICE SENSITIVE	275.71KB	Share
AVR Appendix 3B - Placement and Rights Issue
16/03/12		244.71KB	Share
AVR Trading Halt
14/03/12	PRICE SENSITIVE	22.23KB	Share
AVR Allied announces successful implant of CardioCel
13/03/12	PRICE SENSITIVE	182.38KB	Share
AVR Allied announces updated regulatory strategy for CardioCel
05/03/12	PRICE SENSITIVE	183.35KB	Share
AVR Investor Roadshow Presentation
02/03/12		982.68KB	Share
AVR Half Yearly Report and Accounts
01/03/12	PRICE SENSITIVE	127.73KB	Share
AVR Allied's Coridon to develop HPV Vaccine
28/02/12	PRICE SENSITIVE	153.51KB	Share
AVR Appendix 4C - quarterly
31/01/12	PRICE SENSITIVE	526.44KB	Share
AVR Appendix 3B - Exercise of options
12/01/12		408.26KB	Share
AVR Lapse of listed options
12/01/12		155.27KB	Share
AVR +AVXAvexa Limited - Transfer of Shares/Forms 603 and 604
23/12/11		238.54KB	Share
AVR Featured on BRR following positive Tissue Heart Valve study
16/12/11		186.85KB	Share
AVR Appendix 3B - Exercise of Options
08/12/11		406.19KB	Share
AVR +AVXChange in substantial holding for AVX
08/12/11		216.09KB	Share
AVR AHZ Appoints Dr Julian Chick to Executive Team
07/12/11		160.38KB	Share
AVR AHZ Option Expiry Notice
06/12/11		167.16KB	Share
AVR Positive Results in Tissue Heart Valve Study
05/12/11	PRICE SENSITIVE	556.76KB	Share
AVR Release of Bell Potter Analyst Report on AHZ website
01/12/11		110.4KB	Share
AVR Change of Director's Interest Notice x 2
01/12/11		275.88KB	Share
AVR Appendix 3B
01/12/11		405.98KB	Share
AVR Results of 2011 Annual General Meeting
29/11/11		333.38KB	Share
AVR AGM Presentation
29/11/11		368.26KB	Share
AVR Allied Healthcare Group Appoints a New CEO of Celxcel
22/11/11	PRICE SENSITIVE	332.05KB	Share
AVR Appendix 4C - quarterly
31/10/11	PRICE SENSITIVE	526.1KB	Share
AVR Annual Report to shareholders
27/10/11		6.12MB	Share
AVR Notice of Annual General Meeting/Proxy Form
27/10/11		555.19KB	Share
AVR Appendix 3B
20/10/11		406.81KB	Share
AVR Board Changes and Company Secretary Appointment/Resignation
20/10/11		307.2KB	Share
AVR Sale of Unmarketable Parcels
18/10/11		423.4KB	Share
AVR Notice of Breach of Listing Rules
18/10/11		417.67KB	Share
AVR Replacement Change of Director's Interest Notice
18/10/11		294.53KB	Share
AVR Replacement Initial Director's Interest Notice
18/10/11		211.66KB	Share
AVR Response to ASX query
18/10/11		374.72KB	Share
AVR Re-issue Correction to Appendix 3B
14/10/11		342.24KB	Share
AVR Appendix 3B
14/10/11		341.21KB	Share
AVR Allied Healthcare Increases Holding in Coridon
12/10/11	PRICE SENSITIVE	314.93KB	Share
AVR Coridon Demonstrates 100% Protection using DNA Vaccine
11/10/11	PRICE SENSITIVE	121.21KB	Share
AVR Appendix 3B and Section 708A(5)(e) Notice
05/10/11		356.98KB	Share
AVR Annual Report to shareholders
03/10/11		294.83KB	Share
AVR Corporate Presentation
30/09/11		1.45MB	Share
AVR $5M Equity Funding Package
30/09/11	PRICE SENSITIVE	144.09KB	Share
AVR Trading Halt
28/09/11	PRICE SENSITIVE	23.35KB	Share
AVR Change of Director's Interest Notice x 2
14/09/11		88.12KB	Share
AVR Appendix 3B - Unlisted Options
02/09/11		186.47KB	Share
AVR Preliminary Final Report
01/09/11	PRICE SENSITIVE	441.67KB	Share
AVR Celxcel Granted Tissue Engineering Patent
29/08/11	PRICE SENSITIVE	238.56KB	Share
AVR Appendix 3B - Exercise of Options
05/08/11		186.07KB	Share
AVR Appendix 4C - quarterly
29/07/11	PRICE SENSITIVE	508.67KB	Share
AVR Appendix 3B - Exercise of Options
29/07/11		186.08KB	Share
AVR Ceasing to be a substantial holder
22/07/11		203.28KB	Share
AVR Appendix 3B - Exercise of Options
22/07/11		186.08KB	Share
AVR Becoming a substantial holder from McRae Technology Pty Ltd
20/07/11		1.37MB	Share
AVR DNA Vaccine Developer Coridon in US Collaboration
20/07/11	PRICE SENSITIVE	243.05KB	Share
AVR Becoming a substantial holder from The Metal Group Pty Ltd
18/07/11		488.84KB	Share
AVR +AVXBecoming a substantial holder from AVX
14/07/11		251.64KB	Share
AVR +AVXAvexa holds 16.9% investment in Allied Healthcare Group
14/07/11		62.35KB	Share

REFRESH

First 8 9 10 11 12

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.05		Change 0.450(8.04%)		Mkt cap ! $93.65M

Open	High	Low	Value	Volume
$5.98	$6.07	$5.83	$280.8K	46.71K

Buyers (Bids)

No.	Vol.	Price($)
1	95	$6.02

Sellers (Offers)

Price($)	Vol.	No.
$6.31	200	1

View Market Depth

No.	Vol.	Price($)
1	95	6.020
1	124	6.000
1	2000	5.710
1	943	5.300
1	613	5.240

Price($)	Vol.	No.
6.310	200	1
6.380	3500	1
6.400	449	1
6.500	1230	3
6.600	3823	2

Last trade - 15.49pm 25/08/2025 (20 minute delay)


Last $6.03		Change 0.450 ( 7.68 %)
Open	High	Low	Volume
$5.95	$6.03	$5.95	2183
Last updated 14.05pm 25/08/2025 ?

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available